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 ABSTRACT 
 
Sex specific differences in the immune response have been 
demonstrated in organisms from sea urchins to humans. In mammals, these 
differences have been linked to processes in both the innate and adaptive 
immune responses, and many autoimmune disorders (e.g. systemic lupus 
erythematosus, rheumatoid arthritis, thyroid disease) show a bias towards 
developing in females. However, the complex mechanisms behind these 
discrepancies are not fully understood. CD8+ T-cells are a subtype of 
lymphocytes that are critical to the production of and response to inflammatory 
signaling, so they are likely to play a role in these autoinflammatory processes. 
Previous work in murine naïve CD8+ T-cells has shown that naïve female 
CD8+ T-cells follow different patterns of differentiation after antigen exposure 
than male CD8+ T-cells. Both sexes form the same number of differentiated 
cells, but the ratio of T-cell subsets formed differs between males and females. 
Female CD8+ T-cells tend to differentiate into short-lived effector cells (SLECs) 
that respond directly to invaders and produce large amounts of inflammatory 
cytokines, while their male counterparts tend to differentiate into memory 
precursor effector cells (MPECs) that respond less directly to infection but can 
transition into the pool of cells that forms immunological memory. Co-transfer 
experiments and assays of T-cell function suggest that this altered 
differentiation may be cell intrinsic, as opposed to being a product of different 
niches between males and females. To investigate the potential genomic 
 factors driving sex specific differences in CD8+  T-cell differentiation, I 
performed RNA-seq and PRO-seq on naïve male and female CD8+ cells. 
These data revealed a potential role for the Type I Interferon response and the 
related transcription factor IRF7 in the differentiation of female naïve CD8+ T-
cells. Future investigations will be required to elucidate the exact mechanism 
of this differential expression of the Type I IFN pathway. 
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Background and Significance 
The immune system allows organisms to defend themselves from both 
outside invaders and malignant events inside of the body. Two branches of 
this system, innate and adaptive immunity, work together to provide this 
protection. The innate immune response, whose blueprint extends back to 
single celled organisms, takes advantage of conserved marks from invaders 
(pathogen associated molecular patterns, or PAMPs) to mount a general 
response to injury or infection.1,2 In contrast, the adaptive immune response, 
which is responsible for immunological memory, is comprised of specialized 
cells that generate antigen specific receptors, allowing them to mount a more 
specialized assault.3,4 These systems cross-regulate each other extensively in 
vertebrates through direct cell-cell interactions, cytokine production, and other 
signaling mechanisms.5  This text will focus on one of the key players in the 
adaptive immune response, cytotoxic CD8+ T-cells, and the sex specific 
differences between naïve CD8+ T-cells from males and females.  
CD8+ T-cells are a specific subset of leukocytes that are formed in bone 
marrow (or the fetal liver) and then go through an extensive maturation 
process in the thymus.6 Their main function is to guard against pathogens that 
invade healthy cells by releasing cytolytic factors that can kill infected cells 
(e.g. granzyme B, perforin) and producing cytokines that can activate other 
immune cells from both the innate and adaptive branches.7,8 Aberrant 
activation of these destructive measures would be harmful to the organism, so 
CD8+ T-cells require three separate signals for optimal initiation. First, T-cell 
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receptors (TCRs) must recognize an antigen presented on the surface of 
another cell by major histocompatibility complexes (MHCs). Class I MHCs, 
which interact specifically with CD8+ T-cells, are assembled in the 
endoplasmic reticulum and loaded with peptides derived from protein 
degradation pathways in the cytoplasm.9 Along with this TCR:MHC I 
interaction, CD28 on the T-cell must interact with a B7 ligand (CD80/CD86) on 
the antigen presenting cell.10,11 Finally, the effects of these two activated 
pathways are amplified by the presence of pro-inflammatory cytokines, such 
as Il-12 and Type I interferons (Type I IFNs).12 
CD8+ T-cells accomplish the targeted destruction of presented antigens 
through the specificity of their TCRs, which possess variable regions formed 
by somatic recombination that can recognize a large spectrum of ligands.13 
Each T-cell expresses its own TCR that recognizes a specific ligand, and the 
fate of the T-cell is dependent on their TCR binding to MHC proteins with the 
appropriate affinity (positive selection) and not recognizing self-antigens 
presented in the cortex of the thymus (negative selection).14 After positive and 
negative selection of T-cells, there are very few cells left in the naïve CD8+ 
pool that will respond to any given antigen.15 So, T-cells that can recognize 
antigens currently in circulation must rapidly expand their population to 
respond to the infection or malignancy.16 Once the threatening antigen has 
been withdrawn, most of the responding CD8+ population will die off within ~60 
days, leaving a small subset of memory T-cells to react to the same antigen in 
the future.17,18 
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 Investigations into what differentiates CD8+ T-cells that die after antigen 
exposure from those that live on in the memory pool has led to the discovery 
of several different CD8+ T-cell subsets. Before antigenic stimulation occurs, 
some naïve CD8+ T-cells upregulate the cell surface markers CD44 and 
CD122 that are characteristic of memory T-cells, forming a distinct group from 
true naïve CD8+ T-cells (memory phenotype cells, MPs).19,20 Activated T-cells 
can act as effectors that release cytolytic factors to directly attack infected 
cells and then die, or as memory cells that outlive the immunological challenge 
and allow the organism to respond more rapidly to later exposure to the same 
antigen. This distinction between effector and memory T-cells is not an all-or-
nothing dichotomy. Instead, the activated population is comprised of a diverse 
spectrum of T-cell subsets that fulfill different roles between fully effector and 
fully memory functions.21 Two subtypes of effector T-cells that can be 
distinguished based on Il-7 receptor alpha (CD127) and Killer Cell Lectin Like 
Receptor G1 (KLRG1) expression are short lived effector cells (SLECs, 
CD127lo KLRG1hi) and memory precursor effector cells (MPECs, CD127hi 
KLRG1lo).21–23 SLECs and MPECs both produce cytokines and can induce 
apoptosis in target cells, but MPECs are less cytolytic and are more likely to 
become memory T-cells.24,25 
 Because of the functional disparity between SLECs and MPECs, the 
ratios of each subtype formed by naïve CD8+ T-cell activation would influence 
both the strength of the cytokine response and the development of the 
memory T-cell pool. The ratio of SLECs to MPECs is influenced by cell 
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extrinsic factors, such as inflammatory cytokines (Il-12, Type I IFNs) and 
costimulation by helper CD4+ T-cells.26,27 Our group has elucidated several 
examples of cell intrinsic factors that can influence this SLEC:MPEC ratio. 
Formation of immunological memory is the basis of vaccine efficacy, and 
investigation of the dynamics of memory T-cell formation in newborns is critical 
to understanding and improving vaccine delivery.  Several studies in mice 
have investigated the different expansion ratios, gene expression, and 
chromatin arrangement of adult derived CD8+ T-cells versus their neonatal 
counterparts.28–33 Adult T-cells, produced in the thymus, are more proficient at 
forming memory T-cells, while neonatal T-cells derived from the liver form a 
higher proportion of SLECs, release a different set of cytokines, and respond 
more rapidly to infection.28,33 Additionally, before antigen stimulation and 
expansion, naïve neonatal CD8+ T-cells form a larger population of 
CD44+CD122+ virtual memory (VM) cells (a subset of MP cells), where adult 
cells have a larger true naïve population.33–35 
It is important to note that the differences discussed in previous studies 
are not due to different niches in adults versus neonates and are instead cell 
intrinsic, since transfer of neonatal cells to adults does not cause them to 
expand in the same way as an adult population. Neonatal CD8+ T-cells 
express higher levels of transcription factors associated with effector cells (e.g. 
T-bet, BLIMP1), while adult cells express higher levels of transcription factors 
related to memory cell development (e.g. Eomes).28 The expression of certain 
microRNAs, such as miR-29, miR-130, and miR-150, has also been shown to 
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modulate T-cell population expansion into different subtypes.29,30,36 Loss of 
miR-150 severely attenuates CD8+ T-cell expansion, interfering with the 
development of cytotoxic effector cells.30 miR-29 (as well as miR-150) is a 
negative regulator of the T-cell infection response and is downregulated in 
neonatal cells. On the other hand, miR-130 is upregulated in neonates and is 
connected to T-cell activation.29 Both miR-29 and miR-130 target important 
regulators of T-cell fate determining pathways, including Eomes, T-bet (both 
targeted by miR-29), and IRF1 (targeted by miR-130).29 Lin28b, a negative 
regulator of the developmentally critical miRNA let-7, is more highly expressed 
in neonatal cells.31 Forced expression of Lin28b in adult CD8+ T-cells causes 
them to form a large population of MP cells in a manner similar to neonatal 
populations. 
Another interesting immunological variable affecting CD8+ T-cell 
development that intersects with age is sex.37 It has been well established that 
the immune response differs between the sexes, with females mounting a 
more effective assault against most infections and cancerous cells.38,39 These 
sex specific differences in the immune response extend from sea urchins up to 
humans.40 Many important genes involved in the innate and adaptive immune 
responses, including pattern recognition receptors (e.g. TLR7, TLR8) and 
cytokine receptors, are found on the X chromosome and differentially 
expressed in males and females.41,42 miRNAs, some of which are enriched on 
the X chromosome, have also been shown to modulate immune responses, 
although immune regulation is not limited to these X chromosomal 
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miRNAs.43,44 Immune cells in females, including dendritic cells (DCs) and 
CD8+ T-cells, release higher levels of pro-inflammatory cytokines.39,45 B-cells, 
another type of adaptive immune cells that produce antibodies, are also more 
active in females, spawning higher amounts of immunoglobulin.39 
However, this increased efficiency at responding to immunological 
threats comes with a high cost. While the negative selection of T-cells in the 
thymus is designed to screen out lymphocytes that respond inappropriately to 
self-antigens, this process is not perfect. A slew of serious medical issues, 
including asthma, type 1 diabetes (T1D), systematic lupus erythematosus 
(SLE), rheumatoid arthritis (RA), and thyroid disease are at least partially 
caused by immune cells responding inappropriately to harmless self-
antigens.40 Females are far more prone to developing most common 
autoimmune disorders besides T1D.40,44,46 Eighty percent of autoimmune 
disorder patients are women, and these diseases are a leading cause of death 
for women from puberty onward.39,47 Some autoimmune disorders, such as 
Hashimoto’s hypothyroidism and SLE, are influenced by cycles in the 
expression of female sex hormones, and disorders that affect female sex 
organs (e.g. polycystic ovary syndrome) show a high comorbidity with 
autoimmune disorders.48–50 Autoimmune disorders are not only debilitating, 
but they are also estimated to cost residents of the US alone over $100 billion 
dollars a year in direct healthcare costs.51 Because of this humanistic and 
economic burden, elucidating the mechanisms behind these sex specific 
differences is an important research question. 
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Several factors influencing the differential immune response between 
males and females have been identified. Hormones that are differentially 
expressed between the sexes, such as estrogen, progesterone, and the 
androgens, all influence immune function.39 There are 2 types of estrogen 
receptors, ERα and ERβ, and they are differentially expressed in various 
immune cell types.52 Estrogen increases the strength of the CD8+ T-cell 
response, production of antibodies by B-cells, and the expression of pattern 
recognition receptors in innate immune cells.53 It also plays a role as a direct 
stimulator of the Type II IFN IFNγ, which encourages inflammation.54 The 
transcription factor AIRE is a key component in negative selection, mediating 
the expression of the self-antigens used to screen T-cells for harmful 
autoimmune responses.55 Expression of AIRE is downregulated by estrogen.56 
This downregulation may lead to the survival of more autoreactive T-cells, as 
is the case for AIRE deficient mice.55 Progesterone, which is expressed at 
various points during the menstrual cycle and pregnancy, can alter the 
signaling of multiple innate and adaptive immune cell types and is generally 
anti-inflammatory.38,57 The male associated sex hormones, including 
testosterone, suppress expression of IFNγ, Il-4, and Il-5, and dampen the 
immune response.40 Because of the importance of hormones as cell-extrinsic 
signals for male and female cells, it is critical to study the differences between 
them in an environment that provides the same external signaling to both 
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males and females. This can be achieved through in vitro experiments, or 
through transfer techniques that will be discussed later. 
Known factors that influence the sex specific differences in the immune 
response extend more generally to the expression of genes on the X 
chromosome. While X chromosome inactivation generally prevents the 
expression of the same genes on the two copies present in females, this 
process is not perfect and some genes in humans (and to a lesser extent, 
mice) escape inactivation.58,59 CD4+ T-cells from female SLE patients express 
higher levels of specific genes on the X chromosome than healthy females or 
males with SLE.42 Alterations of sex chromosome ratios in genetic disorders 
have also supported the hypothesis that a higher number of X chromosomes 
will lead to the more autoinflammatory responses normally seen in females. 
Turner’s syndrome describes the situation where only one X chromosome is 
present without a Y chromosome (X0). Turner’s syndrome patients show 
reduced immunoglobulin production, an attenuated lymphocyte response to 
antigens, and a lower propensity to develop SLE, all in line with a more male-
like response than XX females.60,61 The opposite is true for Klinefelter’s 
syndrome (XXY) males, who show a higher propensity for developing 
autoimmune disease than XY males.62  
Considering the previously discovered roles for miRNAs in immune cell 
development and function, it is not surprising that differences in miRNA 
expression also play a role in sex specific differences. For example, miR-29 is 
flanked by putative estrogen response elements, and is selectively 
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downregulated in the frontal cortex of female mice upon exposure to 
radiation.63,64 Other miRNAs, including the miR-182-96-183 cluster, miR-31, 
miR-155, miR-127, and miR-379, are upregulated in female NZB/WF1 mice (a 
model for SLE) as opposed to male NZB/WF1 mice, and all of these miRNAs 
besides miR-155 are expressed more strongly after treatment with estrogen.65 
The miR-182-96-183 cluster and miR-31 have been implicated in 
oncogenesis, while miR-31 has also been shown to influence T-cell 
development through upregulating Il-2 signaling.66–68 BCL6, a transcription 
factor involved in the differentiation of CD4+ T-cells, is targeted by miR-127.69 
The immunomodulatory effects of miR-379 are not well understood at this 
time.65 On the other hand, miR-155 was one of the first miRNAs characterized, 
based on its oncogenic properties in B-cells.70 Activated CD8+ T-cells 
upregulate miR-155, effector T-cells express higher levels of miR-155 than 
memory cells, and this expression of miR-155 is required for response to 
viruses and cancer cells.71,72  
Sex specific differences in the immune system are certainly important to 
consider both for their clinical importance, and the fact that research studies 
must take them into account to obtain valid experimental results.41 However, 
the evolutionary reasoning behind these different responses still remains 
unclear. The aggressive immune response in females may seem 
counterintuitive, since females must carry non-self cells for an extended period 
during pregnancy, but it has been shown that increased levels of certain 
inflammatory cytokines (e.g. Il-6) during pregnancy decreases the likelihood of 
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recurring miscarriages.73 Some of the first investigations into this quandary 
proposed a simple explanation based on two assumptions. The first was that 
since males invested more resources into attracting mates, they had to lose 
some advantages in the immune system. The second key tenant was that the 
main advantage of a strong immune response was increased longevity, and 
females (because of their larger time investment in offspring) stood more to 
gain from extending their lifespan than males.74 This viewpoint has been 
challenged as over simplistic, with counter arguments pointing out that 
longevity is not as directly correlated with a stronger immune response as 
these ideas would suggest because of autoimmune complications and non-
fatal infections.75 It has been suggested that females may produce higher 
levels of immunoglobulins because newborns depend heavily on the 
antibodies inherited from their mother during the first few weeks of life.76 In 
any case, the evolutionary drive behind the more aggressive female immune 
response is still an important area of current investigation. 
 While many general mechanisms for sex specific differences in the 
autoimmune response have already been described, there are still important 
signaling pathways to be explored that are involved in these responses. For 
example, what immunological pathways mediate the stronger CD8+ T-cells 
response mounted by females, and are they cell intrinsic or extrinsic? Prior 
work by our collaborators has shown that naïve male and female CD8+ T-cells 
from mice show different patterns of expansion when exposed to antigen. 
During expansion, the T-cells from each sex form roughly the same number of 
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differentiated cells, but the ratios of effector versus memory subtypes differ. 
Females tend to form a higher proportion of the more inflammatory SLECs, 
while males have a higher proportion of MPECs. Additionally, female CD8+ T-
cells produce higher levels of IFNγ and the cytolytic factor granzyme B upon 
exposure to the inflammatory cytokine Il-12. A series of adaptive co-transfer 
experiments were performed to determine whether these properties were due 
to a different immunological niche for CD8+ T-cell expansion in each sex. 
Equal numbers of male and female naïve CD8+ T-cells responsive to a specific 
antigen were transferred into a male mouse, and it was found that even in the 
male niche, female cells still showed a preference for differentiating into 
SLECs vs MPECs (Yee Mon, unpublished data).  
 Based on these previous results in male and female CD8+ T-cells, we 
became interested in discovering what about the naïve female CD8+ T-cells 
made them different from the males. There were no obvious phenotypic 
differences between male and female CD8+ T-cells in adaptive co-transfer 
experiments where the cells were not exposed to antigen, so we decided to 
use a genomic approach to evaluate the naïve cells. We performed RNA-seq 
and PRO-seq on naïve CD8+  T-cells from males and females and found that 
the Type I IFN response pathway was upregulated in female cells. This 
pathway is critical to the autoimmune response, and discovery of its 
upregulation in female CD8+ T-cells both informs approaches to treating 
autoimmune disorders, and underscores the importance of designing future 
experiments to be mindful of this split between males and females. 
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Materials and Methods 
RNA-seq library preparation and analysis 
 Naïve CD8+ T-cells were isolated from 9-week-old B6 x gBI mice using 
flow cytometry (sorted to select a population that was CD8+CD4- Vb8+Va2+) 
and provided to us by Kristel Joy Yee Mon (Rudd Laboratory, Cornell 
University). 200,000 cells from n=3 males and n=3 females were immediately 
placed into Trizol after sorting. Ribosomal RNA depleted libraries were 
generated using 88-100ng of RNA by the RNA Sequencing Core (Cornell 
University). The resulting libraries were sequenced on an Illumina 
NextSeq500, and aligned to the mm10 genome using TopHat.77 Differentially 
expressed genes were determined using cuffdiff2, with an FDR cutoff of ≤ 
0.05.78,79 
PRO-seq library preparation and analysis 
 PRO-seq libraries were made from naïve CD8+ T-cell nuclei from n=2 
males and n=2 12-week-old B6 x gBI mice provided by the Rudd laboratory. 
80,81 Cells were permeabilized in buffer P (100 mm Tris-Cl, pH 7.5, 10mM KCl, 
250mM sucrose, 5mM MgCl2, 0.5mM CaCl2, 1mM EGTA, 0.05% Tween-20, 
1x EDTA free protease inhibitor (Thermo Scientific), 0.5mM DTT, 40 units 
RiboLock RNase inhibitor) for 10 minutes on ice, then washed in buffer W 
(10mM Tris-Cl pH 8.0, 300mM sucrose, 10mM NaCl, 2mM MgAc2, 0.008% 
Tween20, 0.5mM DTT, 1x EDTA free protease inhibitor, and 40 units 
RiboLock RNase inhibitor), and finally flash frozen in buffer F (50mM Tris-Cl 
pH 8.3, 40% glycerol, 5mM MgCl2, 0.1mM EDTA, 0.5mM DTT, and 40 units 
 13 
 
RiboLock RNase inhibitor) using liquid nitrogen. Between each buffer 
exchange, cells were spun at 1000xg at 4°C for 8 minutes. 
 800,000 frozen nuclei in 50µL buffer F were used for each library. 
Library preparation mostly proceeded as previously described, with a number 
of new modifications.80 The nuclear run-on was performed with 4 biotinylated 
nucleotides at a concentration of 15µM, and the sample was kept at 37°C for 5 
minutes instead of 3 min. Additional washes with equal volumes of acid 
phenol: chloroform and chloroform were added after the Trizol RNA extraction. 
Ethanol precipitations were kept at -20°C for 1 hour, and then spun at 
13000RPM at 4°C for 30 min. Base hydrolysis of the RNA by NaOH was 
performed on ice for 15 min. Mixing of the biotinylated RNA with streptavidin 
beads was carried out for 30 min. Instead of an RNA adaptor, a pre-
adenylated 3ʹ RNA adaptor (Pro3D, App-
GATCGTCGGACTGTAGAACTCTGAAC-/3InvdT/) was used. RppH was used 
for the 5ʹ cap and triphosphate repair, and an RNA adaptor (Pro5R, 
CCUUGGCACCCGAGAAUUCCA) was ligated to the enriched RNA. cDNA 
from each library was amplified at 13 cycles, based on results from a test 
amplification run on an 8% PAGE gel at 250V for 1.5 hours. The libraries were 
then PAGE purified (8% PAGE gel at 250V for 1.5 hours), with bands cut out 
for each library from 140bp to ~1000bp, and DNA was extracted from the gel 
by placing the gel pieces on a rotator at 50°C for 16 hours. Libraries were 
quantified using a Qubit 2.0 fluorometer, and then their size distributions were 
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assessed using an AATI Fragment Analyzer. Sequencing was performed on 
an Illumina NextSeq500 using single end 75bp reads. 
 Adaptors were trimmed from the reads using cutadapt, reads were 
filtered for quality and size ≥ 15 nucleotides, and then the reads were aligned 
to the Mus musculus mm9 genome using bowtie2.82,83 The program 
featureCounts was used to perform read summarization for genes and 
promoter regions.84 Transcriptional regulatory elements were identified using 
dREG.85 TREs were called as promoters if they were located in the area -500 
to +500bp around a known transcription start site. Differentially expressed 
genes and promoters were analyzed using EdgeR, with an FDR cutoff of ≤ 
0.05.86 After analysis of the resulting data, it was found that one of the female 
samples was very low quality (lower number of reads that aligned to the 
mouse genome, sporadic gene expression that did group together with the 
other samples, male or female), so this library was excluded from further 
downstream analyses. An additional set of PRO-seq libraries (n=3 males, n= 3 
males) was prepared at the same time as the RNA-seq samples described 
above using 1 million cells per library, but these libraries were unusable due to 
low DNA yield and sequencing errors. Therefore, while analysis of the RNA-
seq data used n=3 males and n=3 females, analysis of the PRO-seq data only 
uses n=2 males and n=1 females. 
Gene ontology (GO) enrichment analysis and gene set enrichment analysis 
(GSEA) 
 Gene ontology enrichment analysis for the RNA-seq and PRO-seq 
samples was performed using GOrilla, with an FDR cutoff of 0.25.87 The 
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background set used for the comparison was the total number of genes or 
promoters detected by each sequencing technique (n= 10519 genes for RNA-
seq, n= 9006 promoters for PRO-seq). Since GO analysis can often lead to 
the return of multiple categories related to the same signaling processes (e.g. 
“response to interferon-alpha” versus “cellular response to interferon-alpha”), 
the program REViGO was used to compress together these redundant 
terms.88 
 Gene set enrichment analysis was performed using GSEA 3.0, 
including gene sets from GO terms, the MSigDB, and the ImmGen 
Consortium.89,90 The genes or promoters identified during sequencing were 
ranked based on the metric (sign of the log2(fold change)) times the inverse of 
the adjusted P-value, and then compared to curated gene sets using 
GSEAPreranked. 
Motif enrichment analysis 
 Motif enrichment analysis was performed using iRegulon, an app for 
Cytoscape.91,92 The 10K motif collection was used, and the search was 
restricted to the area -500bp to +500bp around the TSS of differentially 
expressed genes from the RNA-seq data. Motifs with a normalized enrichment 
score greater than 3.0 were called as enriched in the differentially expressed 
genes, yielding 103 motifs and 17 motif clusters. 
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Results 
Male and female naïve CD8+ T-cells show different patterns of gene 
expression 
Naïve CD8+ T-cells (CD8+CD4- Vb8+Va2+) were isolated from 9-week-
old B6 x gBI mice using flow cytometry. RNA-seq was performed to evaluate 
the gene expression patterns of male versus female CD8+ T-cells (Figure 1). 
PCA shows genome-wide differences between the male and the female cells 
that were greater than the differences between the replicates (Figure 1A), and 
this clustering of the sexes is supported by sample to sample distance 
clustering (Figure 1B). 50 genes were found to be differentially expressed 
between the male and female naïve CD8+ T-cells (FDR<0.05), with 38 genes 
upregulated in the female cells and 12 upregulated in the male cells. 18 of 
these genes have known functions in the immune system, with 17 upregulated 
in females and 1 upregulated in males. Genes with known immune functions 
and a fold change ≥1.5 are shown in Figure 1C. Notably, most of the members 
of the interferon induced proteins with tetratricopeptide repeat (Ifit) family were 
enriched in the female CD8+ cells, as well as other proteins involved in the 
Type 1 IFN response (e.g. Irf7, Mx1, Oasl2, Isg15).93 
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Figure 1: RNA-seq performed on naïve CD8+ T-cells. N=3 males, 3 females. Genes 
were considered differentially expressed if they achieved an FDR ≤0.05 after cuffdiff2 
analysis. A) Principal component analysis performed on the log transformed counts 
from each of the RNA-seq libraries. B) A sample to sample distance heatmap 
clustering of the libraries based on variance stabilized counts. C) Volcano plot 
highlighting differentially expressed genes involved in the immune response with a 
fold change ≥1.5. Xist, Eif2s3y, Ddx3y, and Kdm5d (genes expressed on sex 
chromosomes that are expected to be differentially expressed in most cell types) are 
excluded for clarity.  
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Figure 1 (continued) 
C. 
 
 
GO analysis was performed to look at enriched pathways and functions 
using GOrilla.87,94 Redundant GO terms were compressed into overarching 
categories using REViGO (Figure 2).88 Out of the three GO aspects (molecular 
function, biological process, and cellular component), enriched categories 
were only found in biological processes. The enriched categories from this 
analysis further demonstrate the connection between the upregulated genes in 
naïve female CD8+  T-cells and the response to viral antigens normally 
mediated by Type 1 IFNs. Two of the categories, “cellular response to 
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interferon-alpha” and “response to interferon-beta,” refer to gene sets directly 
stimulated by 2 types of Type 1 IFNs. Other categories, such as “defense 
response to virus,” “negative regulation of viral genome replication,” and 
“response to biotic stimulus,” show differential enrichment of viral response 
genes. 
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Figure 2: GO biological process enrichment analysis of genes upregulated in female 
naïve CD8+ T-cells. Redundant GO terms have been filtered out using REViGO 
(original categories=23). All categories enriched at an FDR<0.25 are shown. 
 
Sex specific differences between naïve CD8+ T-cells can be linked to specific 
transcription factor motifs 
 To further investigate the pathways involved in the sex specific 
differences between naïve CD8+ T-cells, motif enrichment analysis was 
performed to search for transcription factors that could be modulating gene 
expression in males versus females through binding near gene promoters.91 
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Interestingly, this analysis showed enrichment for motifs from several 
transcription factors related to interferon responses (Table 1). The top 3 
enriched motif clusters all contain motifs for interferon response factors (IRFs), 
transcription factors known to alter gene expression in cells upon stimulation 
with interferons.95  
Table 1: Top 5 enriched motif clusters for differentially expressed genes in naïve 
CD8+ T-cells. The search for motifs was restricted from -500bp to +500bp around the 
transcription start site of each gene. NES= normalized enrichment score. #T= number 
of gene targets containing motifs from a specific motif cluster. 
Motif 
Cluster 
Representative 
Motif ID 
Logo Associated 
TFs 
NES #T 
M1 jaspar-PF0085.1 
 
 
Irf2, Irf7, Irf8, 
Irf6, Irf3, Irf4, 
Irf1, Irf5, Irf9, 
E2f1, Myb, 
Zfp683, Stat1, 
Stat2 
 
8.25 
 
16 
M3 homer-M00094 
 
 
Irf5, Irf6, Irf4, 
Irf3 
5.29 13 
M4 tfdimers-MD00466 
 
Myb, Sfpi1, 
Irf6, Irf2, Irf8, 
Irf1, Irf4, Irf3, 
Irf7, Irf5, 
Prdm1, Elf1, 
E2f1, Pura 
 
5.18 8 
M7 transfac_public-
M00110 
 
Grhl2, Grhl1, 
Grhl3 
 
4.03 4 
M8 taipale-
TAATYYAATTA_
PHOX2B_FULL 
 
Phox2b, 
Hoxd8, 
Hoxb8, 
Phox2a, 
Uncx, Prrxl1, 
Alx4, Isx, 
Pitx3, Dbp, 
Crx 
 
3.96 4 
 
While the binding motifs of these IRFs are difficult to deconvolute due to 
their sequence similarity, cross-referencing the candidate IRFs with the RNA-
seq data shows that the only sex specific IRF is IRF7, which is upregulated in 
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the female naïve CD8+ T-cells. IRF7, which is normally activated by pattern 
recognition receptor signaling in innate immune cells, is one of the master 
regulators of the Type I IFN response.96 IRF7 directly modulates several 
critical members of the Type I IFN response that are differentially expressed 
between males and females, including the Ifit family members Ifit1, Ifit3, and 
Ifi27l2a, Mx1, and Isg15 (Figure 3). 
 
 
Figure 3: Differentially expressed genes between the sexes that are regulated by 
IRF7, based on the results from iRegulon motif enrichment analysis. Notable immune 
regulators upregulated by IRF7 include several members of the Ifit family, Mx1, Isg15, 
Rsad2, and Iigp1. 
 
PRO-seq shows sex specific differential expression at promoters 
 RNA-seq provides information about gene expression, but it does not 
help to identify areas in the genome that may potentially be acting as 
transcriptional regulatory elements. So, in addition to RNA-seq, PRO-seq was 
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performed on naïve CD8+  T-cells purified via magnetic bead enrichment for 
CD8 from n=1 females and n=2 males (Figure 4). PRO-seq allows for the 
evaluation of transcriptional regulatory elements (e.g. promoters, enhancers) 
by identifying areas of divergent transcription.  Additionally, the reads from 
gene bodies can be used to gain information about gene expression in a 
manner similar to RNA-seq. Combining these two classes of information can 
reveal promoters that differ in their levels of RNA Polymerase II occupancy but 
are not in genes being actively transcribed. While the RNA-seq results 
revealed a small number of differentially expressed genes between naïve male 
and female CD8+  T-cells, it is also possible that there is a set of genes poised 
for activation upon antigen stimulation that differs between the sexes (Figure 
4a). In order to test this possibility, we evaluated the subset of genes that have 
sex differential amounts of reads in their promoter regions (here defined as -
1000bp, +500bp from the TSS), but are not differentially expressed according 
to both the gene body reads from PRO-seq and the RNA-seq data (Figure 4b). 
468 promoters were discovered to be differentially occupied between males 
and females. However, it is important to note that the lack of replicates for the 
female samples means that this analysis only constitutes very preliminary 
results. 
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Figure 4: Differential occupancy of potentially poised promoters. A) A genome 
browser shot showing an example of a gene on chromosome 14 (Bcl2l2) with larger 
amounts of reads at its promoter in naïve female CD8+  T-cells, but which is not 
differentially expressed according to PRO-seq and RNA-seq results. Note the 
divergent transcription that marks the promoter region as a transcriptional regulatory 
element. B) Table describing the number of differential promoters, differentially 
expressed genes, and differential promoters from non-differentially expressed genes. 
C) Principal component analysis performed on the log transformed counts from the 
promoters. 
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A. 
 
 
B. 
Differentially Expressed Genes (from 
PRO-seq and RNA-seq) 
450 
Differential Promoters (from PRO-seq) 493 
Differential Promoters from Non-
Differentially Expressed Genes 
468 
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Figure 4 (continued) 
C. 
 
 
PCA shows a divide between the global reads at promoters in the male 
and female samples (Figure 4c).  GO analysis using these promoters showed 
no statistically significant (FDR ≤ 0.25) enriched categories for any GO aspect 
(Figure 5). It is possible that there are no significant overarching signaling 
pathways controlling the differences between the promoters, or that more 
replicates are required to discover potential differences. However, it is 
interesting to note that while none of the GO enrichment categories found by 
GOrilla clear the set significance threshold, the categories called enriched are 
still consistent with alterations in the Type I IFN response pathway (e.g. 
“defense response,” “regulation of defense response to virus by host,” 
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“regulation of CD4-positive, alpha-beta T cell differentiation”) (Figure 5A). In 
addition to the GO enrichment analysis, GSEA was performed to compare the 
differential promoters to CD8+  T-cell gene signatures from the Molecular 
Signatures Database (MSigDB), as well as gene clusters from the 
Immunological Genome Project (ImmGen) Consortium.89,90 A subset of eight 
gene lists from the MSigDB C7 immunological signatures related to SLEC vs 
MPEC gene expression was used, and one of these gene sets describing 
genes that are downregulated in effector cells vs memory cells was found to 
be enriched in the promoters that are more highly transcribed in males (Figure 
5B). This finding is consistent with previous data suggesting that naïve male 
CD8+ T-cells form a higher ratio of MPECs vs SLECs. The promoters that 
have higher amounts of reads in males also show some correlation with 
Cluster V from the ImmGen CD8+  T-cell data. (Figure 5C). This cluster is 
enriched for genes that are activated in naïve, early activated, or memory T-
cells, as opposed to other clusters enriched for effector response genes. This 
may hint to a possible readiness for expression of memory phenotype genes 
in the males, but notably none of the clusters or MSigDB gene sets were 
enriched in the upregulated female promoters. 
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Figure 5: GO enrichment analysis and GSEA results for promoters detected by PRO-
seq. A) GO biological process enrichment analysis of promoters changed in naïve 
CD8+ T-cells. Redundant GO terms have been filtered out using REViGO (original 
categories=21). Note that none of the presented categories pass an FDR cutoff of 
FDR ≤ 0.25. B) GSEA enrichment plot for the differential promoters from non-
differentially expressed genes compared to genes downregulated in effector 
vs. memory CD8+ T-cells. “na_pos” (red) refers to promoters expressed more 
highly in naïve female CD8+ T-cells, while “na_neg” (blue) refers to promoters 
that are downregulated in females/upregulated in males. C) GSEA enrichment 
plot for the differential promoters from non-differentially expressed genes 
compared to Cluster V from Best et al. 2013. “na_pos” (red) refers to 
promoters expressed more highly in naïve female CD8+ T-cells, while 
“na_neg” (blue) refers to promoters that are downregulated in 
females/upregulated in males. 
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A. 
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Figure 5 (continued) 
B. 
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Figure 5 (continued) 
C. 
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Discussion 
 Experiments described herein suggest a potential role for expression of 
Type 1 IFN response genes in the sex specific differences between naïve 
male and female CD8+  T-cells. This is not surprising, considering the fact that 
the Type 1 IFN response has been implicated in many autoimmune disorders 
that are more prevalent in females. For example, the aberrant production and 
activation of Type 1 IFNs through pattern recognition receptors plays a critical 
role in the pathogenesis of SLE.97,98 Expression of a particular haplotype of 
IRF5 is associated with a higher chance of developing SLE.99,100 Blocking 
expression of Type 1 IFNs can prevent the development of arthritis in mice 
with long term Lyme disease.101 More generally, IFNα administered to cancer 
patients causes an increased incidence of autoimmune disorders (e.g. SLE, 
autoimmune vasculitis, thyroid disease), especially in females.102 Additionally, 
Type I IFNs can influence the formation of SLECs versus MPECs after antigen 
exposure. Type I IFNs are required for the development of SLECs in mice, and 
their loss leads to the formation of an effector cell population dominated by 
MPECs.103 
 Type 1 IFNs initiate a complex signal cascade through a shared 
heterodimeric receptor, IFNAR.104 Activation of this receptor causes 
localization of a STAT complex to the nucleus, which in turn activates ~200 
interferon response genes.105 While the STAT complex was first described as 
a STAT1:STAT2 dimer, there are 5 other STAT family members that can also 
modulate the downstream response.105,106 Several factors from this pathway 
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were upregulated in naïve female CD8+  T-cells (fold change=1.5-2.8), many of 
which are involved in recognizing viral RNA. The Ifit family plays an important 
role in the recognition of viral RNA, binding to 5ʹ triphosphate ends or 5ʹ caps 
lacking 2′-O-methylation marks that would normally be present on cellular 
caps.93,107 This binding activity, along with interactions between the Ifits and 
eIF3c (a subunit of the translation preinitiation complex), helps prevent the 
translation of viral RNAs.108 Ifit1 and Ifit2 are known to be highly expressed in 
T-cells.109 Ifit3 and Ifit4 have been tied to the development of autoimmunity in 
mice, and Ifit3 is upregulated in females (fold change=2.4).110,111 Mx proteins 
also help to defend against RNA viruses through a variety of transcriptional 
inhibition mechanisms, and their deletion leaves mice highly susceptible to 
influenza.112 The protein Oasl2 specializes in recognizing double-stranded 
RNA, and overexpression of Oasl2 in mice leads to inhibition of viral 
replication.113,114  
Interferon stimulated gene 15 (Isg15), a ubiquitin-like modifier, is also 
upregulated in female CD8+  T-cells with a fold change of 1.7.115,116 Isg15 can 
act as a cytokine, and can also be attached to both host and viral proteins in a 
process called ISGylation.116 As a cytokine, Isg15 can stimulate the production 
of IFNγ and attract cells from the innate immune response to dispose of cell 
debris.116 ISGylation serves as its main mechanism in intracellular signaling, 
allowing Isg15 to downregulate viral replication as well as tweak host 
translation and exosome secretion.115 Interestingly, while the deletion of Isg15 
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in mice causes increased susceptibility to viral infection and decreased Type I 
IFN responses, the opposite is true for humans who are lacking ISG15.117 
Interferon response factor 7 (IRF7) is required for robust activation of 
the Type I IFN response.96 IRF7 is expressed in an inactive form in the 
cytoplasm and then phosphorylated after activation of pattern recognition 
receptors.118,119 Along with its potential binding partners IRF3 and NFκB, it 
enters the nucleus and induces Type I IFN production. This increased 
production leads to the release of Type I IFNs, which then activate the IFNARs 
on other cells.120 IRF7 is expressed ~1.5 times more highly in the naïve female 
CD8+  T-cells, and its binding motif is also highly enriched in the differentially 
expressed genes from the RNA-seq experiment. This brings up the possibility 
that higher basal expression of IRF7 in naïve female CD8+  T-cells allows for a 
more rapid and/or easily induced response to Type I IFNs in the female cells. 
Previous work has suggested that knocking out IRF7 in mouse CD8+  T-cells 
can reduce the number of effector T-cells specific for a particular antigen, but 
this connection to effector T-cell function must be more extensively 
investigated in the future.121 
While the evidence presented thus far supports the hypothesis that type 
I IFN signaling is stronger in naïve female CD8+  T-cells than in naïve male 
CD8+  T-cells and that this signaling may be related to the increased 
SLEC:MPEC ratio in females, it is important to note the single immune 
regulator upregulated in males versus females: Tbx21, the T-box gene 
encoding for the transcription factor T-bet.  T-bet’s role in CD8+  T-cell 
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differentiation has been studied extensively, and it has been demonstrated 
that higher levels of T-bet push T-cells towards differentiating into SLECs.122 
T-bet’s function as an amplifier of Type I IFN responses seems out of place in 
the male naïve CD8+  T-cells. However, it has been shown in CD4+ T-cells 
exposed to high levels of IFNγ that T-bet can act as a suppressor of the Type 
1 IFN response, indicating that T-bet’s exact role in effector cell differentiation 
is highly context dependent.123 It is possible that in naïve male CD8+  T-cells, 
T-bet may somehow be suppressing Type I IFN signaling. Alternately, the 
higher levels of T-bet in the male CD8+  T-cells may not be enough to have a 
noticeable effect on IFN signaling in the male cells.  
The concept of differentially poised promoters in the sexes is intriguing, 
but unfortunately the currently available data is unable to strongly support or 
deny this hypothesis. PRO-seq experiments using a higher number of 
replicates would be useful in further evaluating transcriptional regulatory 
elements. ATAC-seq, which can detect open regions of chromatin, can also be 
used to look at genomic regions that differ between the sexes in naïve CD8+ T-
cells.124 Additional experiments in mice involving knockdowns of the Type I 
IFN receptor or Irf7 may show that lowering the signal from this pathway can 
cause female CD8+ T-cells to behave more like their male counterparts, while 
the reverse may be true for male cells where these proteins are upregulated. 
Overall, the data presented here suggest that the Type I IFN response 
pathway may control the sex specific differences in naïve CD8+  T-cell 
expansion and differentiation, and further investigations into the effects of Irf7 
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expression on T-cell differentiation would help to expand our understanding of 
autoimmunity. 
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